What the Silent Retina Tells You: Serous Retinal Detachment in Waldenström’s Macroglobulinemia

1Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 2Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 3Department of Internal Medicine, Tergooi Ziekenhuis, Hilversum, The Netherlands 4Lymphoma and Myeloma Center Amsterdam (LYMMCARE), The Netherlands. Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. HemaSphere (2021) 5:2(e527). http://dx.doi.org/10.1097/ HS9.0000000000000527. Received: 28 September 2020 / Accepted: 9 December 2020 What the Silent Retina Tells You: Serous Retinal Detachment in Waldenström’s Macroglobulinemia

[1]  L. Jampol,et al.  UNUSUAL SEROUS RETINAL DETACHMENT IN A PATIENT WITH WALDENSTROM MACROGLOBULINEMIA: A CASE REPORT , 2019, Retinal cases & brief reports.

[2]  M. Gill,et al.  SEROUS MACULAR DETACHMENT ASSOCIATED WITH WALDENSTROM MACROGLOBULINEMIA MANAGED WITH IBRUTINIB: A CASE REPORT AND NEW INSIGHTS INTO PATHOGENESIS , 2018, Retinal cases & brief reports.

[3]  Shivani Reddy,et al.  Angiographically Silent Macular Edema. , 2016, JAMA ophthalmology.

[4]  V. Subrayan,et al.  Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to Waldenström macroglobulinaemia , 2015, British journal of haematology.

[5]  R. J. Courtney,et al.  Bevacizumab therapy and multimodal ultrawide-field imaging in immunogammopathy maculopathy secondary to Waldenström's macroglobulinemia. , 2015, Ophthalmic surgery, lasers & imaging retina.

[6]  K. Kapoor,et al.  Bevacizumab in macular serous detachments associated with Waldenstrom's macroglobulinemia. , 2015, Ophthalmic surgery, lasers & imaging retina.

[7]  A. Mansour,et al.  Paraproteinemic maculopathy. , 2014, Ophthalmology.

[8]  Giorgia Maraone,et al.  Intravitreal Injection of Dexamethasone Implant in Serous Macular Detachment Associated with Waldenström's Disease , 2013, Case Reports in Ophthalmology.

[9]  Gary C. Brown,et al.  Serous macular detachment in Waldenström macroglobulinemia: a report of four cases. , 2013, American journal of ophthalmology.

[10]  Mark W. Johnson,et al.  Immunogammopathy maculopathy associated with Waldenström macroglobulinemia is refractory to conventional interventions for macular edema. , 2013, Retinal cases & brief reports.

[11]  A. Rashid,et al.  Bilateral serous macular detachments in Waldenström’s macroglobulinaemia , 2009, Postgraduate Medical Journal.

[12]  L. Messner,et al.  Bilateral, Persistent Serous Macular Detachments With Waldenström’s Macroglobulinemia , 2005, Optometry and vision science : official publication of the American Academy of Optometry.

[13]  M. Toi,et al.  [VEGF (vascular endothelial growth factor)]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[14]  A. Ho,et al.  Unusual immunogammopathy maculopathy. , 2000, Ophthalmology.

[15]  A. Haas,et al.  Serose abhebung der neuroretina bei morbus Waldenstrom. Eine falldemonstration , 1999 .

[16]  A. Patz,et al.  Irreversible visual loss in Waldenström's macroglobulinaemia. , 1983, The British journal of ophthalmology.

[17]  A. Friedman,et al.  Ocular manifestations of multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy. , 1981, Survey of ophthalmology.